Acquisition Announced Sponsor buyer

Zydus Worldwide DMCC acquisition of Assertio Holdings

US$166m consideration

Announced 8 Apr 2026 · NASDAQ: ASRT · US$23.50 cash per share · 35% premium

Advisers

Assertio Holdings

Target

Financial adviser
Legal adviser
Communications

Zydus Worldwide DMCC

Acquirer

Legal adviser
Target
Assertio Holdings
Acquirer
Zydus Worldwide DMCC
Sponsor
Garda Therapeutics
Target based in
United States
Buyer based in
United Arab Emirates (unverified)
Sector
Pharma

In the league tables

Similar deals

All pharma deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.